Late-course accelerated Hyperfractionation vs. Conventional Fraction Radiotherapy under precise technology plus Concurrent Chemotherapy for Esophageal Squamous Cell Carcinoma: comparison of efficacy and side effects

Conclusion: For ESCC patients, LCAHFRT delivered by image-guided intensity-modulated techniques Plus Concurrent Chemotherapy with cisplatin and docetaxel keeps safety and high CR rate, as well as local control and long-term survival rates.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Hongtao Luo, Shihong Wei, Xiaohu Wang, Ruifeng Liu, Qiuning Zhang, Zhen Yang, Zheng Li, Xiyi Wei, Yuexiao Qi, Lijun Xu Tags: Research Paper Source Type: research